Sinovac, H1N1 Vaccine + Trivalent Inactivated Influenza Vaccine, Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
A single center, randomized clinical trial is to be conducted in healthy adults (18-60 years) to evaluate the safety and immunogenicity and study the cell-mediated Immunity of Sinovac\'s H1N1 influenza A Vaccine (PANFLU.1) with Trivalent Inactivated Influenza Vaccine (ANFLU).
Epistemonikos ID: 2ee971ff7700e64c8bb67ffcdcb581a00b9a9d88
First added on: May 05, 2024